Poulter NR, Prabhakaran D, Caulfield M. Hypertension. The Lancet. 2015;386(9995):801–12. https://doi.org/10.1016/S0140-6736(14)61468-9.
Dixon DL, Salgado TM, Caldas LM, van Tassell BW, The SEM. American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists. J Am Pharm Assoc. 2017;58(4):382–6. https://doi.org/10.1016/j.japh.2018.04.027.
Mancia G, Kreutz R, Brustrom M, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41:1874–2071. https://doi.org/10.1097/HJH.0000000000003480.
Article CAS PubMed Google Scholar
D’Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-187. http://www.ncbi.nlm.nih.gov/pubmed/11448281. Accessed April 15, 2016.
Wallisch C, Heinze G, Rinner C, Mundigler G, Winkelmayer WC, Dunkler D. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: a nationwide registry analysis. Int J Cardiol. 2019;283:165–70. https://doi.org/10.1016/j.ijcard.2018.11.001.
Rana JS, Tabada GH, Solomon MD, et al. Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population. J Am Coll Cardiol. 2016;67(18):2118–30. https://doi.org/10.1016/j.jacc.2016.02.055.
Article PubMed PubMed Central Google Scholar
Cook NR, Ridker PM. Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease. Ann Intern Med. 2016;165(11):786. https://doi.org/10.7326/M16-1739.
Muntner P, Colantonio LD, Cushman M, et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA. 2014;311(14):1406–15. https://doi.org/10.1001/jama.2014.2630.
Article CAS PubMed PubMed Central Google Scholar
Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am College Cardiol. 2014;63(25):2935–59. https://doi.org/10.1016/j.jacc.2013.11.005.
Damen JA, Pajouheshnia R, Heus P, et al. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis. BMC Med. 2019;17(1):109. https://doi.org/10.1186/s12916-019-1340-7.
Article PubMed PubMed Central Google Scholar
Villines TC, Taylor AJ. Multi-ethnic study of atherosclerosis arterial age versus framingham 10-year or lifetime cardiovascular risk. Am J Cardiol. 2012;110(11):1627–30. https://doi.org/10.1016/j.amjcard.2012.07.018.
Rizzoni D, Agabiti-Rosei C, Agabiti-Rosei E. Hemodynamic consequences of changes in microvascular structure. Am J Hypertens. 2017;30(10):939–46. https://doi.org/10.1093/ajh/hpx032.
Article CAS PubMed Google Scholar
Mulè G, Vadalà M, Geraci G, Cottone S. Retinal vascular imaging in cardiovascular medicine: New tools for an old examination. Atherosclerosis. 2018;268:188–90. https://doi.org/10.1016/j.atherosclerosis.2017.11.001.
Article CAS PubMed Google Scholar
Florczak E, Januszewicz M, Januszewicz A, et al. Relationship between renal resistive index and early target organ damage in patients with never-treated essential hypertension. Blood Press. 2009;18(1–2):55–61. https://doi.org/10.1080/08037050902864078.
Tedesco MA, Natale F, Mocerino R, Tassinario G, Calabrò R. Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients. J Hum Hypertens. 2007;21(4):291–6. https://doi.org/10.1038/sj.jhh.1002145.
Article CAS PubMed Google Scholar
Geraci G, Mule G, Costanza G, Mogavero M, Geraci C, Cottone S. Relationship between carotid atherosclerosis and pulse pressure with renal hemodynamics in hypertensive patients. Am J Hypertens. 2016;29(4):519–27. https://doi.org/10.1093/ajh/hpv130.
Doi Y, Iwashima Y, Yoshihara F, et al. Association of renal resistive index with target organ damage in essential hypertension. Am J Hypertens. 2012;25(12):1292-1298. https://doi.org/10.1038/ajh.2012.113
Raff U, Schwarz TK, Schmidt BMW, Schneider MP, Schmieder RE. Renal resistive index–a valid tool to assess renal endothelial function in humans? Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Renal Assoc. 2010;25(6):1869–74. https://doi.org/10.1093/ndt/gfp754.
Cauwenberghs N, Kuznetsova T. Determinants and prognostic significance of the renal resistive Index. Pulse (Basel, Switzerland). 2016;3(3–4):172–8. https://doi.org/10.1159/000442445.
Article PubMed PubMed Central Google Scholar
Mule G, Geraci G, Geraci C, Morreale M, Cottone S. The renal resistive index: Is it a misnomer? Intern Emerg Med. 2015;10(8):889–91. https://doi.org/10.1007/s11739-015-1323-4.
Doi Y, Iwashima Y, Yoshihara F et al. Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension. 2012;60(3):770-777. https://doi.org/10.1161/HYPERTENSIONAHA.112.196717
Pearce JD, Craven TE, Edwards MS, et al. Associations between renal duplex parameters and adverse cardiovascular events in the elderly: a prospective cohort study. Am J Kidney Dis. 2010;55(2):281–90. https://doi.org/10.1053/j.ajkd.2009.10.044.
Article PubMed PubMed Central Google Scholar
Toledo C, Thomas G, Schold JD, et al. Renal resistive index and mortality in chronic kidney disease. Hypertension. 2015;66(2):382–8. https://doi.org/10.1161/HYPERTENSIONAHA.115.05536.
Article CAS PubMed Google Scholar
Geraci G, Mulè G, Paladino G, et al. Relationship between kidney findings and systemic vascular damage in elderly hypertensive patients without overt cardiovascular disease. J Clin Hypertens. 2017. https://doi.org/10.1111/jch.13127.
Association AD. 2 Diagnosis and classification of diabetes: Standards of care in diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20–42. https://doi.org/10.2337/dc24-S002.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter. 2012; 2(Suppl.):1–138.
Geraci G, Mule G, Geraci C, et al. Association of renal resistive index with aortic pulse wave velocity in hypertensive patients. Eur J Prev Cardiol. 2015;22(4):415–22. https://doi.org/10.1177/2047487314524683.
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47. https://doi.org/10.1161/01.cir.97.18.1837.
Article CAS PubMed Google Scholar
Geraci G, Maria Zammuto M, Vadalà M, et al. Choroidal thickness is associated with renal hemodynamics in essential hypertension. J Clin Hypertens (Greenwich). 2020;22(2):245–53. https://doi.org/10.1111/jch.13777.
Article CAS PubMed Google Scholar
Geraci G, Buccheri D, Zanoli L, et al. Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease. Exp Ther Med. 2019;17(4):3255–63. https://doi.org/10.3892/etm.2019.7279.
Article CAS PubMed PubMed Central Google Scholar
Delsart P, Vambergue A, Ninni S, et al. Prognostic significance of the renal resistive index in the primary prevention of type II diabetes. J Clin Hypertens. 2020;22(2):223–30. https://doi.org/10.1111/jch.13819.
Ikee R, Kobayashi S, Hemmi N, et al. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis. 2005;46(4):603–9. https://doi.org/10.1053/j.ajkd.2005.06.006.
Stefan G, et al. Intrarenal resistive index conundrum: systemic atherosclerosis versus renal arteriolosclerosis. Renal Fail. 2019;41(1):930–6.
Kintis K, Tsioufis C, Kasiakogias A, et al. Noninvasive assessment of haemodynamics in resistant hypertension: the role of the renal resistive index. J Hypertens. 2017;35(3):578–84. https://doi.org/10.1097/HJH.0000000000001206.
Comments (0)